trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Rhabdomyosarcoma, Embryonal D018233 1 associated lipids
Gestational Trophoblastic Disease D031901 1 associated lipids
Carcinoma, Papillary, Follicular D018265 1 associated lipids
Rhabdoid Tumor D018335 1 associated lipids
Visceral Pain D059265 1 associated lipids
Lupus Vulgaris D008177 1 associated lipids
Rubinstein-Taybi Syndrome D012415 1 associated lipids
Goldenhar Syndrome D006053 1 associated lipids
Classical Lissencephalies and Subcortical Band Heterotopias D054221 1 associated lipids
Adenomyosis D062788 1 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Li X et al. Role of histone deacetylases(HDACs) in progression and reversal of liver fibrosis. 2016 Toxicol. Appl. Pharmacol. pmid:27396813
Sugiyama KI et al. Epigenetic mutagen as histone modulator can be detected by yeast flocculation. 2016 Mutagenesis pmid:27549112
Zhang XF et al. Trichostatin A Enhances the Apoptotic Potential of Palladium Nanoparticles in Human Cervical Cancer Cells. 2016 Int J Mol Sci pmid:27548148
Scholpa NE et al. Nephrotoxicity of epigenetic inhibitors used for the treatment of cancer. 2016 Chem. Biol. Interact. pmid:27543423
Hou Y et al. Expression Profiles of SIRT1 and APP Genes in Human Neuroblastoma SK-N-SH Cells Treated with Two Epigenetic Agents. 2016 Neurosci Bull pmid:27522594
Huang H et al. Regulation of TWIK-related potassium channel-1 (Trek1) restitutes intestinal epithelial barrier function. 2016 Cell. Mol. Immunol. pmid:25683610
Li QQ et al. Histone deacetylase inhibitor-induced cell death in bladder cancer is associated with chromatin modification and modifying protein expression: A proteomic approach. 2016 Int. J. Oncol. pmid:27082124
Duclot F et al. Trichostatin A (TSA) facilitates formation of partner preference in male prairie voles (Microtus ochrogaster). 2016 Horm Behav pmid:27074037
Toki S et al. The histone deacetylase inhibitor trichostatin A suppresses murine innate allergic inflammation by blocking group 2 innate lymphoid cell (ILC2) activation. 2016 Thorax pmid:27071418
Chen J et al. Histone Deacetylase Inhibitors Trichostatin A and MCP30 Relieve Benzene-Induced Hematotoxicity via Restoring Topoisomerase IIα. 2016 PLoS ONE pmid:27058040
Zhang F et al. Histone Acetylation Induced Transformation of B-DNA to Z-DNA in Cells Probed through FT-IR Spectroscopy. 2016 Anal. Chem. pmid:27046421
Huynh NC et al. Inhibition of Histone Deacetylases Enhances the Osteogenic Differentiation of Human Periodontal Ligament Cells. 2016 J. Cell. Biochem. pmid:27043246
Gupta DK et al. DNA damage regulation and its role in drug-related phenotypes in the malaria parasites. 2016 Sci Rep pmid:27033103
Yeh BW et al. Histone deacetylase inhibitor trichostatin A resensitizes gemcitabine resistant urothelial carcinoma cells via suppression of TG-interacting factor. 2016 Toxicol. Appl. Pharmacol. pmid:26589485
Asgar MA et al. Synergistic anticancer effects of cisplatin and histone deacetylase inhibitors (SAHA and TSA) on cholangiocarcinoma cell lines. 2016 Int. J. Oncol. pmid:26575528
Ranganathan P et al. Histone deacetylase–mediated silencing of AMWAP expression contributes to cisplatin nephrotoxicity. 2016 Kidney Int. pmid:26509586
Selokar NL et al. Buffalo (Bubalus bubalis) SCNT embryos produced from somatic cells isolated from frozen-thawed semen: effect of trichostatin A on the in vitro and in vivo developmental potential, quality and epigenetic status. 2016 Zygote pmid:26503476
Toscano MG et al. SCL/TAL1-mediated transcriptional network enhances megakaryocytic specification of human embryonic stem cells. 2015 Mol. Ther. pmid:25292191
Zhao W et al. A traditional Chinese medicine, Lujiao prescription, as a potential therapy for hypertrophic cardiomyocytes by acting on histone acetylation. 2015 J Chin Med Assoc pmid:25913212
Lin S et al. IL-4 Modulates Macrophage Polarization in Ankylosing Spondylitis. 2015 Cell. Physiol. Biochem. pmid:25896783
Di Zanni E et al. Identification of novel pathways and molecules able to down-regulate PHOX2B gene expression by in vitro drug screening approaches in neuroblastoma cells. 2015 Exp. Cell Res. pmid:25882494
Nordström L et al. DNA methylation and histone modifications regulate SOX11 expression in lymphoid and solid cancer cells. 2015 BMC Cancer pmid:25880212
Samiec M et al. Trichostatin A-mediated epigenetic transformation of adult bone marrow-derived mesenchymal stem cells biases the in vitro developmental capability, quality, and pluripotency extent of porcine cloned embryos. 2015 Biomed Res Int pmid:25866813
Hou H et al. Influence of intra-articular administration of trichostatin a on autologous osteochondral transplantation in a rabbit model. 2015 Biomed Res Int pmid:25866784
Devaney JM et al. Genome-wide differentially methylated genes in prostate cancer tissues from African-American and Caucasian men. 2015 Epigenetics pmid:25864488
Shah S et al. Impact of viral activators and epigenetic regulators on HIV-1 LTRs containing naturally occurring single nucleotide polymorphisms. 2015 Biomed Res Int pmid:25629043
Zhang Q et al. Trichostatin A Protects Against Experimental Acute-on-Chronic Liver Failure in Rats Through Regulating the Acetylation of Nuclear Factor-κB. 2015 Inflammation pmid:25604312
Zhang F et al. Assessment of the effect of trichostatin A on HeLa cells through FT-IR spectroscopy. 2015 Anal. Chem. pmid:25602746
Adi Harel S et al. Reactivation of epigenetically silenced miR-512 and miR-373 sensitizes lung cancer cells to cisplatin and restricts tumor growth. 2015 Cell Death Differ. pmid:25591738
Guo W et al. RASSF5A, a candidate tumor suppressor, is epigenetically inactivated in esophageal squamous cell carcinoma. 2015 Clin. Exp. Metastasis pmid:25579665
Kitchen MO et al. Epidrug mediated re-expression of miRNA targeting the HMGA transcripts in pituitary cells. 2015 Pituitary pmid:25557289
Dagnas M et al. Post-training, intrahippocampal HDAC inhibition differentially impacts neural circuits underlying spatial memory in adult and aged mice. 2015 Hippocampus pmid:25530477
Li PT et al. Increased Histone Deacetylase Activity Involved in the Suppressed Invasion of Cancer Cells Survived from ALA-Mediated Photodynamic Treatment. 2015 Int J Mol Sci pmid:26473836
Mousai M et al. Effect of epigenetic modification with trichostatin A and S-adenosylhomocysteine on developmental competence and POU5F1-EGFP expression of interspecies cloned embryos in dog. 2015 Zygote pmid:25314965
Tiernan AR et al. Trichostatin A affects the secretion pathways of beta and intestinal endocrine cells. 2015 Exp. Cell Res. pmid:25305500
Rempel E et al. A transcriptome-based classifier to identify developmental toxicants by stem cell testing: design, validation and optimization for histone deacetylase inhibitors. 2015 Arch. Toxicol. pmid:26272509
Schlörmann W et al. Influence of miRNA-106b and miRNA-135a on butyrate-regulated expression of p21 and Cyclin D2 in human colon adenoma cells. 2015 Genes Nutr pmid:26559563
Sugimoto H et al. Production of somatic cell nuclear transfer embryos using in vitro-grown and in vitro-matured oocytes in rabbits. 2015 Zygote pmid:24666637
Ma L et al. HDAC5-mTORC1 Interaction in Differential Regulation of Ghrelin and Nucleobindin 2 (NUCB2)/Nesfatin-1. 2015 Mol. Endocrinol. pmid:26357899
Barr MP et al. VEGF-mediated cell survival in non-small-cell lung cancer: implications for epigenetic targeting of VEGF receptors as a therapeutic approach. 2015 Epigenomics pmid:26479311
Liu J and Li Y Trichostatin A and Tamoxifen inhibit breast cancer cell growth by miR-204 and ERα reducing AKT/mTOR pathway. 2015 Biochem. Biophys. Res. Commun. pmid:26436206
Cai D et al. Histone deacetylase inhibition activates Nrf2 and protects against osteoarthritis. 2015 Arthritis Res. Ther. pmid:26408027
Rolando M et al. Contractile actin cables induced by Bacillus anthracis lethal toxin depend on the histone acetylation machinery. 2015 Cytoskeleton (Hoboken) pmid:26403219
Feng W et al. Combination of HDAC inhibitor TSA and silibinin induces cell cycle arrest and apoptosis by targeting survivin and cyclinB1/Cdk1 in pancreatic cancer cells. 2015 Biomed. Pharmacother. pmid:26349994
Liao HF et al. Dnmt3l-knockout donor cells improve somatic cell nuclear transfer reprogramming efficiency. 2015 Reproduction pmid:26159833
Vadie N et al. MYCNOS functions as an antisense RNA regulating MYCN. 2015 RNA Biol pmid:26156430
Ota C et al. Histone deacetylase inhibitor restores surfactant protein-C expression in alveolar-epithelial type II cells and attenuates bleomycin-induced pulmonary fibrosis in vivo. 2015 Exp. Lung Res. pmid:26151196
Singh AK et al. Evaluation of Epigenetic Drug Targeting of Heterogenous Tumor Cell Fractions Using Potential Biomarkers of Response in Ovarian Cancer. 2015 Clin. Cancer Res. pmid:26130461
Lee YR et al. Extracellularly secreted APE1/Ref-1 triggers apoptosis in triple-negative breast cancer cells via RAGE binding, which is mediated through acetylation. 2015 Oncotarget pmid:26125438
Thangavel J et al. Epigenetic modifiers reduce inflammation and modulate macrophage phenotype during endotoxemia-induced acute lung injury. 2015 J. Cell. Sci. pmid:26116574